Harbin Xinguang Optic-Electronics Technology Co (688011) Fair Value & Analysis
Technology · CN · Market cap 6.4B CNY
Analysis
Harbin Xinguang Optic-Electronics Technology Co (688011) currently trades at ¥59.99, while our model-based Fair Value estimate is ¥31.68 — implying the stock looks roughly 47.2% overvalued today. We read business quality at 95/100 (high quality), in the Technology sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).
About the company
Harbin Xinguang Optic-Electronics Technology Co.,Ltd. engages in the research and development, production, and sale of optoelectronic products in China. The company offers automatic monitoring station for fire hazards, PTZ camera, gun bolt, spherical camera, tracked intelligent inspection robot, overhead rail robot, handheld devices, telescope, human body temperature detection camera, portable inertial goniometer, optical axis calibrator, portable imaging parameter measurement system, automated testing system for optical homing search and tracking performance, on-site optical detection system, emissivity measurement system, launcher optical axis calibration equipment, large-size measurement system for spring shaft system, laser echo detection system, customized spectrometers, complex optical scene simulation software, optical aiming system testing equipment, optical axis offset adjustment and testing equipment, composite material paving production line testing equipment, photoelectr…
Open the full interactive analysis →
Similar stocks
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.